Literature DB >> 18331289

Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons.

Alexis M Jeannotte1, Anita Sidhu.   

Abstract

One role of the actin cytoskeleton is to maintain the structural morphology and activity of the pre-synaptic terminal. We sought to determine if the actin cytoskeleton plays a role in regulating interactions between the norepinephrine transporter (NET) and alpha-Synuclein (alpha-Syn), two proteins expressed in the pre-synaptic terminal. In cells transfected with either 0.5 microg/mL or 3 microg/mL of alpha-Syn and 1 microg/mL of NET DNA, treatment with cytochalasin D, an actin depolymerizing agent, caused a dose-dependent decrease and increase, respectively, in [3H]-NE uptake. Protein interactions between NET, beta-actin, and alpha-Syn were modified, along with levels of surface transporters. Treatment of primary brainstem neurons and frontal cortex synaptosomes with cytochalasin D caused a 115% and 28% increase, respectively, in NET activity. Depolymerization of both actin and microtubules did not alter NET activity in cells with 0.5 microg/mL alpha-Syn, but caused an increase in [3H]-NE uptake in cells transfected with 3 microg/mL of alpha-Syn and primary neurons. This is the first direct demonstration of NET activity being regulated via actin and modulated by interactions with alpha-Syn.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331289     DOI: 10.1111/j.1471-4159.2008.05258.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Partial regulation of serotonin transporter function by gamma-synuclein.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

2.  Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes.

Authors:  M Mantovani; D J Dooley; A Weyerbrock; R Jackisch; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.

Authors:  Thomas Haggerty; Joel Credle; Olga Rodriguez; Jonathan Wills; Adam W Oaks; Eliezer Masliah; Anita Sidhu
Journal:  Eur J Neurosci       Date:  2011-04-01       Impact factor: 3.386

4.  Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.

Authors:  Seth W Perry; Justin Barbieri; Ning Tong; Oksana Polesskaya; Santosh Pudasaini; Angela Stout; Rebecca Lu; Michelle Kiebala; Sanjay B Maggirwar; Harris A Gelbard
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

5.  Stimulation of norepinephrine transporter function by fasudil, a Rho kinase inhibitor, in cultured bovine adrenal medullary cells.

Authors:  Noriaki Satoh; Yumiko Toyohira; Hideaki Itoh; Han Zhang; Susumu Ueno; Masato Tsutsui; Kojiro Takahashi; Nobuyuki Yanagihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-01       Impact factor: 3.000

Review 6.  Synuclein modulation of monoamine transporters.

Authors:  Adam W Oaks; Anita Sidhu
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

Review 7.  Fluid markers of synapse degeneration in synucleinopathies.

Authors:  Alba Cervantes González; Olivia Belbin
Journal:  J Neural Transm (Vienna)       Date:  2022-02-11       Impact factor: 3.575

8.  Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum.

Authors:  Alexis M Jeannotte; John G McCarthy; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-10-08       Impact factor: 3.046

9.  Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.

Authors:  Jonathan Wills; Joel Credle; Thomas Haggerty; Jae-Hoon Lee; Adam W Oaks; Anita Sidhu
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

10.  Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.

Authors:  Bidisha Roy; George R Jackson
Journal:  Hum Mol Genet       Date:  2014-01-14       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.